Clover Health Investments, Corp. (CLOV) is a publicly traded company in the Healthcare — Medical - Healthcare Plans industry listed on NASDAQ. This overview shows the latest price, key valuation ratios, profitability metrics and financial-health indicators used by fundamental investors.
Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. The company leverages its proprietary software platform, the Clover Assistant, to provide both Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) health plans for individuals eligible for Medicare. In addition to its insurance operations, Clover Health also engages in non-insurance-related business ventures.
Is Clover Health Investments, Corp. stock overvalued or undervalued in 2026?
As of October 30, 2026, Clover Health Investments, Corp. (CLOV) trades at $4.46 with no positive earnings over the last twelve months, according to Kaplio. No valuation verdict: it has no earnings to calculate a P/E from.
Kaplio overview: Clover Health Investments, Corp.
Market cap $2B · 52 weeks $2 – $5 (18 % below the high) · P/E no earnings · 2027 expected P/E 44.4× · Dividend none · Next earnings November 4, 2026 · expected EPS $-0.00 · Closing price, Oct 30 · accounts published Aug 5.
- Valuation: P/Sales 0.9× (no earnings).
- Business: ROIC −5 % (weak).
- Balance sheet: Net debt/EBITDA 0.9× (solid).
- Earnings: 4 of 8 (uneven).
What would it be worth at its usual multiples?
No valuation verdict: it has no earnings to calculate a P/E from.
What matters in pharma: 1 of 4 pass
- R&D / Revenue 0.0 %, fails.
- Gross margin 18.5 %, fails.
- ROIC −4.6 %, fails.
- Net debt / EBITDA 0.9×, passes.
Against its peers (reference peers) — Clover Health Investments, Corp.: P/E —; EV/EBITDA —; ROIC -4.6 %; $2.4B. Oscar Health, Inc. (P/E 21.7×; EV/EBITDA 6.8×; ROIC 23.0 %; $7.9B), Centene Corp. (P/E 23.4×; EV/EBITDA 7.6×; ROIC 2.2 %; $33.9B), Humana Inc. (P/E 39.2×; EV/EBITDA 18.4×; ROIC 4.5 %; $49.8B).
Profitability
| Return on Equity | -5.38% |
| Return on Invested Capital | -4.62% |
| Return on Assets | -2.55% |
| Gross Margin | 18.57% |
| Operating Margin | -0.74% |
| Net Margin | -0.74% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 1.50 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 0.47 |
Price Performance
| 1 month | +5.44% |
| 3 months | +6.95% |
| Year-to-date | +89.79% |
| 1 year | +26.35% |
| 3 years | +389.68% |
| 5 years | -42.97% |
Dividend History
| Date | Amount |
|---|---|
| 2021-08-23 | $0.1000 |
Amounts adjusted for stock splits.
Related companies: CVS · CI · HUM · CNC · OSCR
Explore sector: Healthcare · Medical - Healthcare Plans
More sections of CLOV: Financials · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks